Fear Conditioning Interventions for PTSD
Trial Summary
The trial does not specify if you need to stop taking your current medications. However, if you are using neuroleptics, you must not have taken them within one year prior to the study.
Research shows that fear conditioning and extinction-based therapies, like exposure therapy, can reduce fear symptoms in PTSD patients, although some may experience a return of fear. Combining these therapies with approach-avoidance training may further reduce fear and prevent its return.
12345The research does not provide specific safety data for fear conditioning therapy, but it is commonly used in exposure therapy for anxiety and PTSD, suggesting it is generally considered safe in clinical settings.
13678Fear conditioning treatment for PTSD is unique because it focuses on understanding and modifying the fear learning processes, such as fear extinction and inhibition, which are often impaired in PTSD. This approach uses experimental paradigms to study and potentially improve the way individuals with PTSD respond to fear-related cues, offering a novel method compared to traditional therapies that may not specifically target these underlying fear mechanisms.
19101112Eligibility Criteria
This trial is for adults aged 18-70 with current PTSD, diagnosed through specific assessments (CAPS and SCID). It's also open to trauma-exposed healthy controls without any history of psychiatric disorders or PTSD. Participants must be willing to undergo experiments involving avoidance of stimuli.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment visit to establish baseline measures before experimental visits
Experimental Visits
Participants undergo an emotional learning paradigm and fMRI scan over two consecutive days
Follow-up
Participants are monitored for any delayed responses or effects post-experiment